Biopharma PEG will be attending TIDES USA 2026 in Boston this May and welcomes researchers to Booth 826 to explore our latest developments in high-purity PEG derivatives.
Event Details:
Date: May 11–14, 2026
Location: Hynes Convention Center, Boston, MA, USA
Booth No.: 826
PEG derivatives are indispensable tools in modern life sciences, offering enhanced solubility, improved stability, and reduced immunogenicity. Biopharma PEG supports a wide range of applications, including:
Drug Conjugates & Delivery:
Monodispersed and multi-arm PEGs for ADCs, PROTACs, and polymer–drug conjugates.
Lipid Nanoparticles & Bioconjugation: P
EG linkers for functionalization and surface modification.
Chemical Biology & Click Chemistry:
Functional PEGs with azide, maleimide, amine, thiol, and NHS ester groups.
Polydispersed PEGs (M.W. 200–43 KDa):
Monodispersed PEGs (Units 1–48):
About Biopharma PEG
Biopharma PEG provides a comprehensive portfolio of high-purity PEG derivatives to support drug discovery, chemical biology, and pharmaceutical research. With over 5,000 products, including monodispersed, polydispersed, and multi-arm PEGs, we deliver reliable solutions for ADCs, lipid nanoparticles, PROTACs, and click chemistry applications.
We look forward to connecting with fellow researchers at Booth 826 and discussing how our PEG solutions can enhance your projects.
